Refractory Generalized Myasthenia Gravis
3 clinical trials · Condition
◉ Watch Refractory Generalized Myasthenia Gravis
| Record | Firm | Date |
|---|---|---|
| Extension Study of ECU-MG-301 to Evaluate Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (NCT02301624) | Alexion Pharmaceuticals, Inc. | 2014-11-12 |
| Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study) (NCT01997229) | Alexion Pharmaceuticals, Inc. | 2013-12-01 |
Track Refractory Generalized Myasthenia Gravis automatically
Every clearance here is in the API, with alerts when new ones post.